Gemelli Biotech

This innovative test is applicable to patients experiencing symptoms of chronic diarrhea and stomach pain. By measuring the levels of two validated IBS biomarkers, anti-CdtB and anti-vinculin, ibs-smart can accurately diagnose diarrhea-predominant or mixed-type IBS (IBS-D or IBS-M). These biomarkers are not commonly elevated in patients with constipation-predominant IBS (IBS-C).

The validation study for ibs-smart demonstrates that elevated biomarkers indicate IBS with an impressive positive predictive value of up to 100%. Furthermore, this test effectively distinguishes between IBS and Inflammatory Bowel Disease (IBD). It is important to note that only a licensed physician can order ibs-smart and make an IBS diagnosis.

To make the testing process convenient, ibs-smart offers the option to work with a doctor online for ordering and evaluation. The results, which are clear and actionable, are directly emailed to you along with a post-test consultation by phone with a doctor. The brand also provides educational materials and resources for healthcare providers who want to offer this test to their patients.

ibs-smart not only helps diagnose IBS accurately but also enables individuals to start the right treatment quickly, potentially avoiding unnecessary procedures like colonoscopies. With its licensed, patented antibody blood test, ibs-smart is revolutionizing IBS diagnostics and paving the way for personalized treatment options